Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benchmark Maintains Buy on Omnicell, Lowers Price Target to $38

Author: Benzinga Newsdesk | February 09, 2024 03:34pm
Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $42 to $38.

Posted In: OMCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist